Orchid Logo
Embryo Report
PGT-WGSPGT-MPGT-SR
Log inContact Us
Orchid Logo

Embryo Report

Advanced genetic screen for your embryos. Prevent your child from inheriting a predisposition to a condition that runs in your family.

VIEW DETAILSGET ACCESS

Couple Report

Our preconception test measures your future child's genetic predisposition to disease. Mitigate your risk.

For Patients

OverviewRisk CalculatorGuidesBook a Call

For Clinicians

Log inContact Us
Skip to article body

Your Guide to Genetic Testing for Embryos

Your Guide to Genetic Testing for Embryos

The world of genetics is constantly evolving, and it can be overwhelming to understand all the options for genetic testing. While no single test can uncover every genetic risk, learning about your options early in your family-building journey can empower you to make informed choices.

One option available to those pursuing IVF (in vitro fertilization) is embryo screening, scientifically known as preimplantation genetic testing (PGT). This process involves testing embryos created during IVF for specific genetic information, helping to screen for potential concerns.

How Does Embryo Screening Work?

  • Embryo screening requires a small sample of cells from the embryo.
  • An embryologist at your IVF center carefully removes 5-6 cells from the trophectoderm (the part of the embryo that forms the placenta), not the inner cell mass (which develops into the fetus). This is considered a low risk procedure.
  • The screening on these samples can provide valuable insights into the embryo, although it is important to note that it does not replace genetic testing during pregnancy.

There are several types of embryo screening (PGT), each tailored to specific needs:

1. PGT-A (Preimplantation Genetic Testing for Aneuploidy)

  • What it screens for: Chromosomal abnormalities (called aneuploidies)

  • How it works: Counts chromosomes to detect:

    • Whole chromosome abnormalities: For example, Down Syndrome is caused by an extra copy of chromosome 21
    • Segmental aneuploidies: Extra or missing pieces of chromosomes
  • Purpose: Helps identify embryos with the correct number of chromosomes to improve the chances of a healthy pregnancy

2. PGT-M (Preimplantation Genetic Testing for Monogenic Disorders)

  • What it screens for: Specific genetic conditions known to run in the family

  • Who it’s for: Families with a history of genetic conditions, such as:

    • Autosomal dominant conditions (e.g., BRCA mutations)
    • Autosomal recessive conditions (e.g., cystic fibrosis, Tay-Sachs disease)
    • X-linked conditions (e.g., Hemophilia A)
  • How it works: Typically this is a test developed for the family's unique condition(s). This process, called “probe development,” may require DNA samples from family members and take weeks to months to complete

At Orchid, this process can be shortened and family members may not be required as probes are not needed. This can facilitate quicker timelines and accommodate more diverse family structures. 

3. PGT-P (Preimplantation Genetic Testing for Polygenic Conditions)

  • What it screens for: Conditions influenced by many genes as well as environmental factors, such as:

    • Diabetes
    • Mental health conditions
    • Heart disease
  • How it works: Evaluates an embryo’s genetic predisposition to these conditions compared to the general population

  • Purpose: Can help families prioritize embryos at lower risk for chronic conditions. While this testing is not meant to diagnose or eliminate risk, it provides insight into potential genetic risk factors

4. PGT-WGS (Whole Genome Sequencing)

This is the most comprehensive form of embryo screening offered through Orchid.

  • How it’s different:

    • Traditional PGT examines <1% of the genome, while PGT-WGS looks at over 99%

    • Combines all embryo screening (PGT) options in one:

      • PGT-A: Detects smaller chromosomal changes (microdeletions/duplications)
      • PGT-M: Eliminates the need for family-specific probes, speeding up the process
      • PGT-P: Provides more robust risk scores by analyzing a wider genetic landscape, including ancestry
    • Plus more: Screens for hundreds of genetic forms of neurodevelopmental disorders, birth defects, and hereditary cancers

  • Advantages:

    • Provides 100x more data from the same biopsy as traditional PGT
    • Accessible to families for whom traditional PGT-M might not be feasible due to technical challenges or unavailable family samples
    • Reduces more genetic risks than previously possible

__wf_reserved_inherit

What’s Next?

If you’re considering whole genome sequencing for your embryos, Orchid’s genetic counselors can help guide you through the options to determine what’s best for you and your family-building goals.

By understanding the different types of testing available, you can take a proactive step toward making informed decisions about your future family’s health. Get started with a complimentary genetic counseling call here.

Recent Articles

Genetic risk scores are most accurate in the populations with the most data

Genetics

Genetic risk scores are most accurate in the populations with the most data

Genetic risk scores have more predictive power in people of European descent because they are based on large genetic studies which have been…

Can Autism be Inherited? 5 Myths about Autism Genetics

Genetics

Can Autism be Inherited? 5 Myths about Autism Genetics

Autism spectrum disorder (ASD) has a strong genetic component, but many misconceptions persist about its inheritance and risk factors. This …

Exploring the yield of PGT-WGS from young adult ICU admissions

Genetics

Exploring the yield of PGT-WGS from young adult ICU admissions

We review a study of genetic sequencing data from young-adult ICU admissions to evaluate the fraction of disease-causing variants which woul…

Have healthy babies.

PRODUCTS

Embryo ReportCouple Report

FOR PATIENTS

OverviewRisk CalculatorGuidesBook a Call

FOR CLINICIANS

OverviewScience

© 2026 Orchid

Orchid
GET STARTED